- Home
- ESNT vs WGSWW Comparison
ESNT vs WGSWW Comparison
Compare ESNT & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESNT
- WGSWW
- Stock Information
- Founded
- ESNT 2008
- WGSWW 2017
- Country
- ESNT Bermuda
- WGSWW United States
- Employees
- ESNT N/A
- WGSWW 1000
- Industry
- ESNT Property-Casualty Insurers
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- ESNT Finance
- WGSWW Technology
- Exchange
- ESNT Nasdaq
- WGSWW Nasdaq
- Market Cap
- ESNT N/A
- WGSWW N/A
- IPO Year
- ESNT 2013
- WGSWW N/A
- Fundamental
- Price
- ESNT $61.82
- WGSWW $0.07
- Analyst Decision
- ESNT Buy
- WGSWW
- Analyst Count
- ESNT 5
- WGSWW 0
- Target Price
- ESNT $66.80
- WGSWW N/A
- AVG Volume (30 Days)
- ESNT 557.6K
- WGSWW 36.6K
- Earning Date
- ESNT 11-07-2025
- WGSWW 02-18-2025
- Dividend Yield
- ESNT 2.02%
- WGSWW N/A
- EPS Growth
- ESNT N/A
- WGSWW N/A
- EPS
- ESNT 6.87
- WGSWW N/A
- Revenue
- ESNT $1,263,558,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- ESNT $4.19
- WGSWW N/A
- Revenue Next Year
- ESNT $1.54
- WGSWW N/A
- P/E Ratio
- ESNT $8.94
- WGSWW N/A
- Revenue Growth
- ESNT 2.04
- WGSWW 50.79
- 52 Week Low
- ESNT $51.61
- WGSWW $0.17
- 52 Week High
- ESNT $65.90
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- ESNT 54.30
- WGSWW 38.15
- Support Level
- ESNT $60.08
- WGSWW $0.06
- Resistance Level
- ESNT $62.52
- WGSWW $0.08
- Average True Range (ATR)
- ESNT 1.41
- WGSWW 0.01
- MACD
- ESNT 0.06
- WGSWW -0.00
- Stochastic Oscillator
- ESNT 86.07
- WGSWW 5.80
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.